Ann: Preliminary Final Report, page-3

-Expenses increased by 79% to $2,715,450 (2017: $1,519,993) with the single largest contributor being the $709,698 Research and Development costs.
-Net loss from ordinary activities was up 99.4% to $2,646,618 (2017: $1,327,159).
-Expenses by function
Administration (1,603,110)

Just had a proper look and reckon share holders need some further explanation on the above.

Especially look at the accounting for Administration? where did the money go. Its a fare question.

Research and Development- for what?

I will be asking at the AGM.